Simcere Pharmaceutical Group (HKSE:02096) Net Interest Margin (Bank Only) %

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

HKSE:02096 Simcere Pharmaceutical Group Ltd HKSE:02096
93 GF Score
Price HK$12.35
GF Value HK$10.89
Valuation Modestly Overvalued
View Full Analysis

What is Simcere Pharmaceutical Group Net Interest Margin (Bank Only) %?

Net Interest Margin (Bank Only) % only applies to banks.

HKSE:02096
93GF Score
Simcere Pharmaceutical Group Ltd HKSE:02096
Net Interest Margin (Bank Only) % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Simcere Pharmaceutical Group (HKSE:02096) Overvalued in 2026?

Based on GuruFocus' analysis, Simcere Pharmaceutical Group stock appears to be overvalued. The current stock price of HK$12.35 is trading 13.4% above its estimated GF Value™ of HK$10.89. GuruFocus considers Simcere Pharmaceutical Group to be Modestly Overvalued.

Key valuation signals for HKSE:02096:

  • Net Interest Margin (Bank Only) %:
  • GF Value™: HK$10.89 vs. price of HK$12.35 (13.4% above fair value)
  • GF Score™: 93/100

No single metric tells the full story. See the HKSE:02096 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Simcere Pharmaceutical Group Business Description

Other Exchanges S2P:Germany
Address No. 699-18, Xuanwu Road, Xuanwu District, Jiangsu Province, Nanjing, CHN, 210042
Simcere Pharmaceutical Group Ltd is engaged in the R&D, production, and commercialization of pharmaceuticals focused on generic pharmaceuticals. The company has a diversified product portfolio focused on therapeutic areas, including, neuroscience, anti-oncology, autoimmune, and antiinfection. The company's products include Endostar, Enweida, Enzeshu, Iremod, Quviviq, Cosela, Sanbexin and Others.
93GF Score

Get the complete analysis for HKSE:02096

Net Interest Margin (Bank Only) % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

HK$12.35
Price
HK$10.89
GF Value